featured
Single-Dose Dupilumab in Children Aged 6 Months to <6 Years With Severe Uncontrolled Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase 2, Open-Label Study of Single-Dose Dupilumab in Children Aged 6 Months to <6 Years With Severe Uncontrolled Atopic Dermatitis: Pharmacokinetics, Safety and Efficacy
J Eur Acad Dermatol Venereol 2020 Sep 07;[EPub Ahead of Print], AS Paller, EC Siegfried, EL Simpson, MJ Cork, B Lockshin, MP Kosloski, MA Kamal, JD Davis, X Sun, G Pirozzi, NMH Graham, A Gadkari, L Eckert, M Ruddy, A BansalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.